Yang Shao

Dr. Yang Shao


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2014 in Molecular and Clinical Oncology
Verified
Journal Article
Open access
PDF file
YSYang Shao
Yang Shao
HJHongguo Jiang
Hongguo Jiang
XWXiaoming Wu
Xiaoming Wu
YLYing Luo
Ying Luo
WTWenru Tang
Wenru Tang
The present study aimed to investigate the effects of p16 hypermethylation on the risk of nasopharyngeal carcinoma (NPC) quantitatively, through a meta‑analysis of available case‑control studies including malignant and normal NPC tissue samples. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were extracted and pooled to assess the strength of the association between p16 hypermethylation and NPC risk. A total of 9 studies, including 406 NPC and 376 control cases, were identified for meta‑analysis. Statistically significant ORs of p16 hypermethylation were obtained from the NPC and control groups (OR=19.53; 95% CI: 9.54‑39.97; P=0.685). The meta‑analysis indicated that p16 hypermethylation significantly increases NPC risk.

27 February 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SLShaoshuo Li
Shaoshuo Li
YSYang Shao
Yang Shao
HCHao Chen
Hao Chen
JWJianwei Wang
Jianwei Wang
Objective. To identify the potential pharmacological targets of Jisuikang (JSK) for the treatment of spinal cord injury (SCI) using network pharmacology. Methods. The bioactive compounds of JSK herbs and their corresponding potential SCI targets were obtained from three traditional Chinese medicine (TCM) databases. SCI-related therapeutic target genes were obtained from the Comparative Toxicogenomics Database and the GeneCards Database. The common target genes between the JSK compounds and SCI-related therapeutic targets were screened using GO/KEGG functional enrichment and protein-protein interaction (PPI) analyses to identify hub genes and their categories of biological function. Gene expression distribution and receiver operating characteristic curve (ROC) analyses were used to identify probable SCI-related target genes. Molecular docking was used to quantify molecular interactions between target genes and the bioactive compounds of JSK. Results. A total of 183 JSK bioactive compounds and 197 target genes for the treatment of SCI were screened and assessed. The target genes were enriched primarily in drug metabolism and in inflammation-related biological processes. Ten genes with statistical significance were identified as therapeutic SCI-related target genes of JSK. Molecular docking experiments demonstrated that the proteins of these 10 genes docked with binding energies of less than 5kcal/mol with the bioactive compounds in JSK. Conclusion. This study showed that the anti-SCI effects of JSK may be mediated through numerous bioactive components, multiple gene targets, and inflammation-related pathways and provided potential novel targets for directed therapies for treating SCI. These results provide a foundation for further experimental investigations into treatment options for SCI.

27 July 2026 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
TXTian-Ge Xia
Tian-Ge Xia
YZYi-Jie Zhang
Yi-Jie Zhang
SLShao-Shuo Li
Shao-Shuo Li
YZYi Zhou
Yi Zhou
WTWen-Yu Tian
Wen-Yu Tian
JWJianwei Wang
Jianwei Wang

18 January 2025 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
ZTZhi Tang
Zhi Tang
HLHeng-yang Lu
Heng-yang Lu
XYXiao Yang
Xiao Yang
MWMao Wu
Mao Wu
JYJunfeng Yang
Junfeng Yang
JWJianwei Wang
Jianwei Wang
Spinal cord injury (SCI) is a devastating neurological disease in which astrocytes play a central role. Understanding the relationship between different subtypes of astrocytes and neuron subtypes during the progression of SCI is critical to understanding the disease. In this study, single-cell RNA sequencing (scRNA-seq) was used to analyze the transcriptome data of acute, subacute and intermediate stages of SCI in mice as well as normal tissues. Different subtypes of astrocytes and neuronal cells were identified and their dynamic changes and functionalities during the development of SCI. An intriguing discovery was the identification of a specific subtype of astrocytes characterized by unique expression of Gap43, Vim, Aldoc, and Mt1. This subtype of cells shows similarities in gene expression with neurons and potentially transitioned into neurons during the course of SCI. Furthermore, we have uncovered the important role of the glycolytic pathway in this cellular transformation process. Furthermore, through cellular interaction analysis, we validated pathways (mdk-ptprz1,ptn-ptprz1,ptn-sdc3) associated with the potential conversion of these specific cell subsets into neurons. Finally, these cells were observed by fluorescence microscopy and critical gene expressions were validated by Western blot. The results of this study not only deepen our understanding of the mechanisms underlying SCI, but also provide new insights and opportunities for the development of novel therapeutic strategies and interventions.

9 June 2026 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
TXTiange Xia
Tiange Xia
YZYijie Zhang
Yijie Zhang
SLShaoshuo Li
Shaoshuo Li
YZYi Zhou
Yi Zhou
WTWenyu Tian
Wenyu Tian
JWJianwei Wang
Jianwei Wang
Large language models (LLMs) are increasingly used by patients to obtain health information. Postoperative rehabilitation after anterior cruciate ligament reconstruction (ACLR) has distinct phase boundaries and safety considerations. Therefore, responses should be not only clear and understandable, but also medically accurate, safe, and stage-fit. This study compared the performance of three publicly accessible LLMs in standardized post-ACLR rehabilitation question answering. This was a standardized, blinded, expert-rated comparative evaluation study. On a single prespecified data collection day in March 2026, 30 English-language rehabilitation questions were submitted separately to GPT-5.4, Doubao, and MiniMax-M2.7. The questions covered five postoperative rehabilitation phases. Responses were anonymized and randomly reordered before blinded rating by five orthopaedic clinicians across five domains: Accuracy, Safety, Stage-fit, Completeness, and Understandability. Paired non-parametric tests, effect size analyses, intraclass correlation coefficients, and linear mixed-effects modelling were used for statistical analysis. A total of 90 model-generated responses and 450 expert rating records were included. Overall scores differed significantly among the three models (Friedman χ² = 46.067, P < 0.001; Kendall's W = 0.768). GPT-5.4 achieved the highest overall score (4.61 ± 0.13), followed by MiniMax-M2.7 (4.53 ± 0.19), whereas Doubao had the lowest score (3.86 ± 0.29). GPT-5.4 performed best in Accuracy, Safety, and Stage-fit; MiniMax-M2.7 achieved the highest score for Completeness; and Doubao achieved the highest mean score for Understandability. Inter-rater agreement was good [ICC(3,k) = 0.893], and sensitivity analysis supported the primary findings. The three models showed distinct rating profiles in standardized single-turn post-ACLR rehabilitation question answering. Evaluation of patient-facing rehabilitation information should not rely solely on linguistic fluency, but should prioritize medical accuracy, safety, and Stage-fit. These findings provide preliminary benchmark evidence in a phase-sensitive rehabilitation setting, but they should not be interpreted as evidence supporting clinical implementation, clinician substitution, or patient benefit.

1 October 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
TXTiange Xia
Tiange Xia
XSXiaoyan Sun
Xiaoyan Sun
ZJZhiwei Jiang
Zhiwei Jiang
YZYijie Zhang
Yijie Zhang
YZYi Zhou
Yi Zhou
JWJianwei Wang
Jianwei Wang
Background: Osteoarthritis (OA) is increasingly understood as a whole-joint organ disease involving cartilage, synovium, subchondral bone, and the local immune-stromal microenvironment. Synovial fibroblasts and fibroblast-like synoviocytes (FLS) participate in synovitis, matrix remodeling, cartilage-synovium crosstalk, pain-associated microenvironments, and disease heterogeneity. However, the knowledge structure, main knowledge sources, and frontier evolution of OA-related synovial fibroblast research remain incompletely mapped. Methods: We retrieved publications on OA-related synovial fibroblasts/fibroblast-like synoviocytes (OA-FLS) published from 2006 to 2025 from the Web of Science Core Collection (WOSCC) and Scopus. After integration and deduplication, Bibliometrix, CiteSpace, VOSviewer, and Python were used to analyze annual publication trends, national and institutional contributions, author and journal distributions, collaboration networks, global and local citation structures, keyword co-occurrence, trend topics, and thematic evolution. Results: A total of 1,881 publications were included, comprising 1,642 articles and 239 reviews. Annual output increased from 53 publications in 2006 to 142 in 2025, with an annual growth rate of 5.32%. China contributed the largest number of publications, whereas international collaboration remained relatively limited. Keyword and citation structures indicated a strong influence of RA-FLS-related knowledge sources. Recent hotspots increasingly involved synovitis, immune-stromal interaction, extracellular vesicle-mediated communication, fibrosis, pain-associated fibroblast states, and single-cell/spatially related studies. Conclusion: OA-FLS research has expanded from early studies of inflammatory mediators and catabolic pathways toward questions about fibroblast states, tissue location, immune-stromal interaction, and clinical phenotype association. These findings suggest a gradual movement from RA-derived conceptual borrowing toward more OA-contextualized interpretation, although this pattern should be understood as a bibliometric inference rather than direct mechanistic proof. Future studies need to clarify which OA-FLS states have stable, reproducible, and pathologically meaningful disease associations through standardized sampling, multicenter validation, spatial localization, functional experiments, and integration with clinical phenotypes.